Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

NeoTherapeutics' lead small molecule advances toward clinical trials in AD

Nov. 22, 1996

Guilford's orally active neuroimmunophilin highly effective in animal models of Parkinson's disease

Nov. 22, 1996

Lamotrigine now available in France

Nov. 22, 1996

Antiparkinsonian skin patch enters pivotal phase II trial

Nov. 22, 1996

Approval recommended for Elan's gel formulation of diazepam

Nov. 21, 1996

SIBIA Neurosciences reports preclinical results with NAChR-selective compounds

Nov. 21, 1996

NIH to conduct clinical trial of Ampalex in AD

Nov. 21, 1996

First pivotal trial for panic disorder Rx

Nov. 20, 1996

Cephalon/Leo neurological disease collaboration

Nov. 20, 1996

Antimigraine drug from Vanguard to enter pivotal trials

Nov. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...